Medical Devices Group

  • Community
  • Webinars
  • Jobs
  • Events
  • Contact
  • Go Premium
« Back to Previous Page
Jana Černá
Regulatory Affairs - MEDKONSULT medical technology
January 2019
Conformity Assessment of IIa MD
< 1 min reading time

Hi, I have some doubts about conformity assessment of IIa MD. We apply Annex II with exclusion of section 4. When we launch a new MD or when we make any substantial change, we always undergo an approval process with our NB.

Recently, I have come across a manufacturer of IIa MD who claims that they launch their products without prior NB approval provided that the given MD is within the scope of the Full Quality Assurance certificate already issued, i.e., if the certificate was issued, let’s say, for catheters and they have developed a new catheter model, they can CE-mark the product and freely market it.

Most companies use the Annex II conformity assessment process to achieve CE Marking. In this process, the NB reviews your Technical File for conformity, and also reviews your quality system for conformity with regulatory requirements in the applicable directives. As part of the Annex II process, the NB will audit your design process to ensure that you have adequate design controls, and that your process for establishing and maintaining a Technical File is adequate. Once your company has adequately addressed any findings from the audit, the NB will issue your company a Full Quality Assurance (FQA) CE Certificate in accordance with Annex II.3. Once you have the certificate, your company will be able to launch new products without prior approval from the NB. The only requirement is that the new products are within the scope of the Annex II.3 certificate.

I went through the MDD several times and it seems that it depends on the interpretation of your NB. Do you agree?

Thanks in advance for the discussion.

Marked as spam
Posted by Jana Černá
Asked on January 18, 2019 5:38 pm
505 views
  • Follow
  • Unfollow
  • Report spam

Meet your next client here. Join our medical devices group community.

Private answer
Robert Packard

Dear Jana,
This is not really an issue of interpretation. Each NB must have procedures in place for review design changes (i.e., significant changes). Some NBs have a liberal policy that allows a company with an Annex II certificate to make changes and launch new products within their scope without pre-approval--including Class IIa and Class IIb devices (e.g., BSI). Other NBs have a more rigorous process that requires the company to submit a detailed change notification and provide technical documentation (e.g., NSAI). Finally, some NBs require a new submission. These are important questions to ask when considering your selection of a NB, and it has obvious impact upon cost and timelines for new product launches.

Marked as spam
  • Report spam
Private answer
Jana Černá

Dear Robert,
Thank you for your answer.
I'm just wondering: do you happen to know which part of Annex II of MDD supports this approach of NBs? I thought that it might have been the case but I can't figure out why they are allowed to choose a less strict approach towards their manufacturers launching new products...

Thanks.

Marked as spam
  • Report spam
« Back to Previous Page

Please log in to post questions.

  • Go to WP login page

Stay connected with us.

By signing up you are agreeing to our Privacy Policy.

Categories

  • Capital/Investment
    • Business Model
    • Funding
  • Careers
  • Design/Devel
    • Design
    • Development
    • Human Factors
    • Labeling
    • Material Selection
    • R&D
    • Trials and Post-Market
  • Featured
  • Industry
    • Announcements
    • Device Tax
    • Hospital and Health Care
    • Innovation
    • Medtech
  • LinkedIn, etc.
  • Markets
    • Africa
    • Americas
    • Asia
    • Australia
    • Europe
  • Regulating
    • CE Marking
    • EU
    • FDA
    • FDA/EU etc.
    • Notified Bodies
    • Quality
    • Regulatory
  • Selling
    • Distribution
    • Intellectual Property
    • Marketing/Sales
    • Reimbursement
  • Worth bookmarking!
Feature your job here.
logo

Companion to LinkedIn's 350,000 member community

  • Contact
  • Medical Device Marketing
  • In Memoriam
  • Medical Device Conference

The Medical Devices Group   |   Copyright © Terms, Conditions & Privacy

Medical Devices Group
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.